InnovAge (NASDAQ:INNV - Get Free Report) is set to issue its quarterly earnings results after the market closes on Tuesday, November 5th. Analysts expect the company to announce earnings of ($0.03) per share for the quarter. InnovAge has set its FY 2025 guidance at EPS.Parties interested in participating in the company's conference call can do so using this link.
InnovAge (NASDAQ:INNV - Get Free Report) last announced its earnings results on Tuesday, September 10th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. InnovAge had a negative net margin of 2.79% and a negative return on equity of 7.43%. The firm had revenue of $199.40 million during the quarter, compared to analyst estimates of $190.19 million. During the same period in the prior year, the business earned ($0.09) EPS.
InnovAge Stock Up 0.9 %
Shares of INNV traded up $0.05 during midday trading on Tuesday, hitting $5.90. The stock had a trading volume of 21,304 shares, compared to its average volume of 37,236. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.25 and a quick ratio of 1.25. The firm has a market cap of $799.43 million, a price-to-earnings ratio of -36.88 and a beta of 0.39. The company has a 50 day simple moving average of $5.96 and a two-hundred day simple moving average of $5.28. InnovAge has a twelve month low of $3.52 and a twelve month high of $6.61.
Insider Transactions at InnovAge
In related news, insider Nicole Damato sold 4,372 shares of the firm's stock in a transaction on Monday, September 16th. The shares were sold at an average price of $5.95, for a total value of $26,013.40. Following the completion of the transaction, the insider now directly owns 240,795 shares of the company's stock, valued at approximately $1,432,730.25. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.41% of the company's stock.
Analyst Upgrades and Downgrades
Separately, KeyCorp started coverage on InnovAge in a research report on Friday, October 11th. They set a "sector weight" rating for the company.
Check Out Our Latest Analysis on INNV
InnovAge Company Profile
(
Get Free Report)
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
See Also
Before you consider InnovAge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.
While InnovAge currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.